Changeflow GovPing Pharma & Drug Safety USPTO Grants Patent for Tableted Cannabinoid Ch...
Routine Notice Added Final

USPTO Grants Patent for Tableted Cannabinoid Chewing Gum

Favicon for changeflow.com ChangeBridge: Patent Grants - Pharma (A61K)
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has granted a patent (US12582602B2) to NordicCan A/S for a tableted chewing gum composition containing cannabinoids. The patent describes a layered chewing gum with water-insoluble and water-soluble components designed for oral administration of cannabinoids.

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582602B2 to NordicCan A/S for a novel tableted cannabinoid chewing gum. The patent abstract details a composition comprising a plurality of particles, including a gum base and water-soluble chewing gum ingredients, structured in at least two layers. The composition is designed for oral administration and includes one or more cannabinoids.

This patent grant is primarily an intellectual property event and does not impose new regulatory obligations on pharmaceutical companies or drug manufacturers. However, it signifies a new development in the formulation and delivery of cannabinoid-based products, which may be relevant for companies operating in the pharmaceutical and cannabis sectors. Compliance officers should note this development as it pertains to potential future product innovation and market exclusivity in this evolving area.

Source document (simplified)

← USPTO Patent Grants

Tableted cannabinoid chewing gum with tableted modules

Grant US12582602B2 Kind: B2 Mar 24, 2026

Assignee

NordicCan A/S

Inventors

Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen

Abstract

A tableted chewing gum composition for oral administration of cannabinoids includes a plurality of particles, including a first population of particles having water-insoluble gum base and a second population of particles having water-soluble chewing gum ingredients. The composition constitutes at least two layers, where a first layer of the composition has water-insoluble gum base and a second layer of the composition, which is cohered to and adjacent to the first layer, has water-soluble chewing gum ingredients. The second layer is free of water-insoluble gum base, and the composition includes one or more cannabinoids.

CPC Classifications

A61K 47/02 A61K 9/19 A61K 31/515 A61K 9/01

Filing Date

2023-10-24

Application No.

18493276

Claims

22

View original document →

Named provisions

Tableted cannabinoid chewing gum with tableted modules

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582602B2

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 4453 Cannabis
Activity scope
Drug Labeling
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Cannabis Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.